Although no definite proof is available, our observations covering 6 years suggest that repeated attacks of streptococcal pharyngitis occurring in the same individual are usually due to Group A streptococci of different types. Reinfection with the same type was never observed, suggesting that type-specific immunity may develop. At the present time, however, serological evidence of such immunity is meager.
REVIEW OF LITERATURE
Fothergill and Lium studied the bactericidal activity of the blood of 4 convalescent scarlet fever patients (1) . Two of these patients recovered without developing complications; the other 2 developed otitis media, in one instance accompanied by mastoiditis, and in the other by adenitis. Only the 2 patients with purulent sequelae showed an increase in the bactericidal activity of the blood for the homologous streptococcus.
Hare reported the development of specific bactericidal properties in the blood of patients during the course of puerperal sepsis (2) .
Spink and Keefer studied the streptococcidal power of defibrinated blood obtained from 30 erysipelas patients (3) . An increase in bactericidal power for the homologous organism during the course of the disease was observed in one-third of the cases.
Chandler and Taussig, in a recent article, reported that the blood of 2 rheumatic children, who were carriers of Group A streptococci, were bactericidal for the homologous strains (4) . The blood of 2 carriers of Group C streptococci was also found to contain homologous bactericidal antibodies. Tillett (5) showed that sera obtained from patients acutely ill with a variety of infectious diseases, such as pneumonia, meningococcus meningitis, tuberculous pleurisy, as well as diseases due to streptococci, was highly bactericidal for certain strains of streptococci. This property disappeared as the patients recovered and was not considered to represent a specific immune response.
Swift and Hodge described the occurrence of type-specific anti-M precipitins in the sera of patients following streptococcal infections (6) . Positive reactions were obtained, both in patients who developed rheumatic sequelae and in those who did not.
Walker (7) has reported the presence of typespecific agglutinins for the homologous streptococcus, demonstrable by the slide agglutination technique of Griffith, in the sera of 6 of 22 patients. The 6 positive reactions were obtained with sera of individuals recovering from purulent streptococcal infections (otitis media, empyema, and paronychia accompanied by axillary adenitis). Rantz et al. reported the development of agglutinins for the homologous types, demonstrable by the slide agglutination technique, in 13 of 22 cases of scarlet fever (8) . Diefendorf (9) was able to demonstrate mouse protective antibodies in the sera of 10 of 14 patients. Six of these 10 sera were obtained from patients recovering from scarlet fever and 4 from rheumatic subjects during the fourth week of the rheumatic attack.
MATERIAL
Outbreak of streptococcal pharyngitis. As previously reported, an outbreak of pharyngitis, due to a Group A streptococcus of a single type, type 36, occurred in this institution during the winter of 1941-1942 (10, 11) . Six cases occurred in October, 9 in November, followed by 2 in December and one in January (making a total of 18 cases). Sera for the determination of antistreptolysin 0 titer, slide agglutination, and anti-M precipitin reactions were collected at frequent intervals, following the upper 151 respiratory infection, from 16 of these 18 patients. Bacteriostatic tests with whole blood were not started until March 1942 when the outbreak had subsided and all the children were afebrile. EXPERIMENTAL Slide agglutination reactions. The sera of 10 children were tested by the slide agglutination method (Griffith) with the homologous as well as with heterologous types of Group A streptococcus (12) . Five to 15 sera from each individual, obtained at intervals ranging from 1 day to 5 months after infection, were used. Slight agglutination occurred with a few sera from 7 children when tested with a strain of the homologous type. In every instance, however, equally strong or stronger reactions were observed with heterologous types. The results obtained by the slide agglutination test were therefore considered to be non-specific.
Anti-M precipitin reactions. The sera of 14 of these 18 children were tested for type specific anti-M precipitins (Lancefield (13) A modification of the technique described by Todd (15) was used. Most of the tests were done with the epidemicinducing strain, type 36 streptococcus, but in some experiments, recently isolated cultures of other types were included. All the cultures were preserved by drying on small pieces of filter paper in vacuo, according to the technique described by Brown (16) . Numerous cultures of each strain were prepared. On the day before the test, one of these cultures was opened and the filter paper transferred to broth which was incubated for 18 to 20 hours. On the morning of the experiment, dilutions of the cultures were made in broth.
The blood was collected the morning of the test; 3 cc. of blood were placed in test tubes containing 1 mgm. of ' In an outbreak of pharyngitis due to type 32 streptococcus (14) , a few sera obtained after the subsidence of the upper respiratory infection were tested for type specific anti-M precipitins. It was found that sera which gave positive precipitin reactions with homologous M extracts also reacted with M extracts prepared from heterologous types.
heparin (Hynson, Westcott, and Dunning). Nine-tenths cc. of heparinized blood was pipetted into test tubes of soft glass (12 cm. in length with an outside diameter of 7 mm.). One-tenth cc. of a 10-' or 10-6 dilution of culture was added. In some instances, 0.1 cc. of a 1: 2,000,000 dilution was used. The number of bacteria inoculated varied considerably in different experiments. The best results were obtained when from 10 to 30 microorganisms were added to 0.9 cc. of blood. One-tenth cc. of the infected blood was transferred immediately to 15 cc. of melted agar containing 0.5 cc. of horse blood and a "pour" plate made. The test tube containing the blood was then sealed by heat, placed in a shaking machine, and shaken for 3 hours, at moderate speed, while incubating at 370 C. At the end of this period, 0.1 cc. was again transferred to 15 cc. of melted agar containing 0.5 cc. horse blood and a second "pour" plate made.
The number of colonies in the plates poured before and after incubation were counted. The horse blood was added to facilitate the counting of the colonies and exerted no demonstrable bacteriostatic effect.
The results of these bacteriostatic tests with the whole blood of 16 patients, 3½2 to 17 months following pharyngitis due to type 36 streptococcus, are shown in Table I .
The tests recorded in Table I show a well marked difference between the bacteriostatic activity of the blood of children who had recovered from pharyngitis due to type 36 streptococcus, and that of children who had escaped this infection and who served as controls.
Children in whom the clinical symptoms due to this upper respiratory infection were mild or lacking, as well as those in whom they were moderately severe, developed this property. It was not correlated with the rise in antistreptolysin 0 titer or the development of rheumatic sequelae. The bacteriostatic activity persisted for many months and in some instances could be demonstrated more than a year after the upper respiratory infection. In 3 patients, however, Cases 5, 6 , and 14, who were tested after intervals of 16 to 17 months, a decrease in the bacteriostatic action of the blood was apparent.
Although the uniformity of the results obtained suggested that the bacteriostatic activity of these patients was definitely related to the type 36 streptococcal pharyngitis, it was thought of interest to determine whether this property was absent before infection. In 6 instances, the bacteriostatic activity of sera obtained before and after the upper respiratory infection was compared. Heparinized blood obtained from 152 Table II . Unfortunately, only small amounts of sera obtained before the attack of pharyngitis were available and the tests therefore could not be repeated. Although the bacteriostatic activity of the sera was weak, in 4 of the 6 cases, a definite difference between the sera taken before and after infection was apparent.
Specificity of the bacteriostatic activity of the blood of patients, following recovery from streptococcal pharyngitis Strains of heterologous types (types 6, 15, 19, 26, and 39), isolated from patients with acute pharyngitis, were included in many of the tests. It was shown by Todd (17) that the virulence of streptococci can be judged by their ability to grow in the blood of normal individuals. Although the heterologous types were recently isolated, most of these strains appeared to be of low virulence and failed to grow in human blood unless a fairly large number of bacteria were inoculated. With the homologous strain, type 36, a considerable variation in the size of the inoculum did not alter the results. With the heterologous types, the bacteriostatic activity of the blood of many of the children varied with the number of bacteria inoculated. In many instances, when a small inoculum was used, the blood appeared to be bacteriostatic, whereas, with a larger inoculum, the bacteria were able to multiply. Furthermore, the findings with heterologous types were often equivocal because no definite contrast between the child who had recovered from the type 36 streptococcal pharyngitis and the children chosen to serve as controls was obtained. In most instances, however, the bacteriostatic effect was more marked against the homologous type 36 than against heterologous types.
Absorption. It was thought of interest to determine whether the bacteriostatic activity of sera obtained from children whose whole blood inhibited the growth of type 36 streptococcus could be reduced by absorption with the homologous strain. The inactivated serum in each instance was divided into 3 parts: one part was not absorbed, one was absorbed with the homologous strain, and one with a streptococcus of a heterologous type. Two parts of serum were mixed with one part of heat-killed bacterial sediment, and incubated at 370 C. for 30 minutes. The mixture was allowed to stand overnight in the ice box, centrifuged the following morning, and the clear serum pipetted off. Five-tenths cc. of each of these sera was added to 0.9 cc. of whole heparinized blood, obtained from a child known to have no bacteriostatic action against type 36 streptococcus.
The indirect method of doing bacteriostatic tests, using serum and blood from a control, usually gave less definite results than those obtained with whole blood of children following recovery from type 36 pharyngitis. In most instances, however, the bacteriostatic action of serum absorbed with the homologous type was reduced, as compared with the unabsorbed serum or that absorbed with a heterologous type. A protocol illustrating these findings is presented in bility to the non-specific bactericidal action of sera obtained from febrile patients (5) . Although all the children whose blood was used in the bacteriostatic tests were afebrile and had no complaints or symptoms, in a few experiments, the bacteriostatic action of fresh serum was compared with that of whole blood obtained from the same individual. In spite of the fact that the blood was definitely bacteriostatic, it was found that type 36 streptococcus multiplied freely in the serum. The bactericidal action of fresh serum obtained from one patient with active rheumatic fever, whose temperature ranged between 101.8 to 1030 F. on the day of the test, was also tried with type 36 streptococcus. No bactericidal effect was noted. Thus, no evidence 2 heterologous types. In one of these patients, the bacteriostatic action of the blood for type 19 streptococcus had been determined be-fore the infection occurred, and in the other, the first test was done 3 weeks after the attack of pharyngitis. Further tests were performed with the blood of both children, at frequent intervals for periods of 5 to 6 months. In some instances, the blood was set up in duplicate and inoculated with vatying numbers of bacteria. In one experiment, the bacteriostatic activity of whole blood was compared with that of freshly obtained serum.
The data presented in Table IV During the course of the outbreak of pharyngitis, due to type 36 streptococcus, the failure of certain children to contract this infection, in spite of exposure, was striking. It was thought that if the resistance of these individuals was due to a previous infection with this type of streptococcus, bacteriostatic properties might still be demonstrable in their blood. The results of these tests, however, were entirely negative. It may be that, after a lapse of time, bacteriostatic activity is no longer demonstrable in the blood and that these humoral antibodies represent a temporary expression of a more permanent cellular immunity.
Bacteriostatic tests failed to elucidate the nature of the resistance to streptococcal pharyngitis of individuals who escaped infection. The 
